{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:44:47Z","timestamp":1764906287555,"version":"3.37.0"},"reference-count":199,"publisher":"Aging and Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2025]]},"DOI":"10.14336\/ad.2025.0010","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T01:08:46Z","timestamp":1738890526000},"page":"0","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the Therapeutic Promise of Epigenetics in Vascular Cognitive Impairment and Vascular Dementia"],"prefix":"10.14336","author":[{"given":"Sharmelee","family":"Selvaraji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Mosberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Y.","family":"Fann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell KP.","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Li Hsian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruma V.","family":"Arumugam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2025.0010-1","unstructured":"Prince M, Wim A, Guerchet M, Ali GC, Wu YT, Prina M (2015). World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. Research Report: Alzheimer\u2019s Disease International; London."},{"key":"key-10.14336\/AD.2025.0010-2","doi-asserted-by":"crossref","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013). The global prevalence of dementia: a systematic review and meta-analysis. Alzheimers Dement, 9: 63-75.","DOI":"10.1016\/j.jalz.2012.11.007"},{"key":"key-10.14336\/AD.2025.0010-3","doi-asserted-by":"crossref","unstructured":"Delgado-Morales R, Esteller M (2017). Opening up the DNA methylome of dementia. Mol Psychiatry, 22: 485-496.","DOI":"10.1038\/mp.2016.242"},{"key":"key-10.14336\/AD.2025.0010-4","doi-asserted-by":"crossref","unstructured":"Maji M, Khajanchi S (2025). Mathematical models on Alzheimer's disease and its treatment: A review. Phys Life Rev, 52: 207-244.","DOI":"10.1016\/j.plrev.2025.01.004"},{"key":"key-10.14336\/AD.2025.0010-5","doi-asserted-by":"crossref","unstructured":"Venkat P, Chopp M, Chen J (2015). Models and mechanisms of vascular dementia. Exp Neurol, 272: 97-108.","DOI":"10.1016\/j.expneurol.2015.05.006"},{"key":"key-10.14336\/AD.2025.0010-6","doi-asserted-by":"crossref","unstructured":"Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E (2003). Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol, 60: 85-90.","DOI":"10.1001\/archneur.60.1.85"},{"key":"key-10.14336\/AD.2025.0010-7","doi-asserted-by":"crossref","unstructured":"Wolters FJ, Ikram MA (2019). Epidemiology of Vascular dementia. Arterioscler Thromb Vasc Biol, 39: 1542-1549.","DOI":"10.1161\/ATVBAHA.119.311908"},{"key":"key-10.14336\/AD.2025.0010-8","doi-asserted-by":"crossref","unstructured":"Biesbroek JM, Biessels GJ (2023). Diagnosing vascular cognitive impairment: Current challenges and future perspectives. Int J Stroke, 18: 36-43.","DOI":"10.1177\/17474930211073387"},{"key":"key-10.14336\/AD.2025.0010-9","doi-asserted-by":"crossref","unstructured":"Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang FL, Skinner K, Tasaki C, Jagust WJ (2000). Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol, 57: 191-196.","DOI":"10.1001\/archneur.57.2.191"},{"key":"key-10.14336\/AD.2025.0010-10","doi-asserted-by":"crossref","unstructured":"Sachdev P, Kalaria R, O'Brien J, Skoog I, Alladi S, Black SE, Blacker D, et al. (2014). Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord: 28: 206-218.","DOI":"10.1097\/WAD.0000000000000034"},{"key":"key-10.14336\/AD.2025.0010-11","unstructured":"Murray ME, Meschia JF, Dickson DW, Ross OA (2010). Genetics of Vascular Dementia. Minerva Psichiatrica, 51:9-25."},{"key":"key-10.14336\/AD.2025.0010-12","doi-asserted-by":"crossref","unstructured":"Srinivasan V, Braidy N, Chan EK, Xu YH, Chan DK (2016). Genetic and environmental factors in vascular dementia: an update of blood brain barrier dysfunction. Clin Exp Pharmacol Physiol, 43:515-521.","DOI":"10.1111\/1440-1681.12558"},{"key":"key-10.14336\/AD.2025.0010-13","doi-asserted-by":"crossref","unstructured":"Kalaria RN, Akinyemi R, Ihara M (2016). Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta, 1862:915-925.","DOI":"10.1016\/j.bbadis.2016.01.015"},{"key":"key-10.14336\/AD.2025.0010-14","doi-asserted-by":"crossref","unstructured":"Gold G (2003). Vascular dementia: a diagnostic challenge. Int Psychogeriatr, 15:111-114.","DOI":"10.1017\/S1041610203009050"},{"key":"key-10.14336\/AD.2025.0010-15","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n GC (2004). Controversies of Vascular dementia. Seminars in cerebrovascular diseases and stroke, 4: 117-120.","DOI":"10.1053\/j.scds.2004.10.006"},{"key":"key-10.14336\/AD.2025.0010-16","doi-asserted-by":"crossref","unstructured":"Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH (2014). Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Front Aging Neurosci, 6: 311.","DOI":"10.3389\/fnagi.2014.00311"},{"key":"key-10.14336\/AD.2025.0010-17","doi-asserted-by":"crossref","unstructured":"Grimm A (2021). Impairments in Brain Bioenergetics in Aging and Tau Pathology: A Chicken and Egg Situation? Cells, 10: 2531.","DOI":"10.3390\/cells10102531"},{"key":"key-10.14336\/AD.2025.0010-18","doi-asserted-by":"crossref","unstructured":"Zeviani M, Viscomi C (2022). Mitochondrial Neurodegeneration. Cells, 11: 637.","DOI":"10.3390\/cells11040637"},{"key":"key-10.14336\/AD.2025.0010-19","doi-asserted-by":"crossref","unstructured":"Farhat E, Devereaux MEM, Cheng H, Weber JM, Pamenter ME (2021). Na+\/K+-ATPase activity is regionally regulated by acute hypoxia in naked mole-rat brain. Neurosci Lett, 764: 136244.","DOI":"10.1016\/j.neulet.2021.136244"},{"key":"key-10.14336\/AD.2025.0010-20","doi-asserted-by":"crossref","unstructured":"Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, Pinton P (2012). ATP synthesis and storage. Purinergic Signal, 8: 343-357.","DOI":"10.1007\/s11302-012-9305-8"},{"key":"key-10.14336\/AD.2025.0010-21","doi-asserted-by":"crossref","unstructured":"Juzekaeva E, Nasretdinov A, Gainutdinov A, Sintsov M, Mukhtarov M, Khazipov R (2017). Preferential Initiation and Spread of Anoxic Depolarization in Layer 4 of Rat Barrel Cortex. Front Cell Neurosci, 11: 390.","DOI":"10.3389\/fncel.2017.00390"},{"key":"key-10.14336\/AD.2025.0010-22","unstructured":"Selvaraji S, Poh L, Natarajan V, Mallilankaraman K, Arumugam TV (2019). Negative Conditioning of Mitochondrial Dysfunction in Age-related Neurodegenerative Diseases. Cond Med, 2: 30-39."},{"key":"key-10.14336\/AD.2025.0010-23","doi-asserted-by":"crossref","unstructured":"Kasparov\u00e1 S, Brezov\u00e1 V, Valko M, Horeck\u00fd J, Mlyn\u00e1rik V, Liptaj T, Vancov\u00e1 O, Ulicn\u00e1 O, Dobrota D (2005). Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int, 46: 601-611.","DOI":"10.1016\/j.neuint.2005.02.006"},{"key":"key-10.14336\/AD.2025.0010-24","doi-asserted-by":"crossref","unstructured":"Du J, Ma M, Zhao Q, Fang L, Chang J, Wang Y, Fei R, Song X (2013). Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia. Neuroscience, 231: 345-352.","DOI":"10.1016\/j.neuroscience.2012.11.062"},{"key":"key-10.14336\/AD.2025.0010-25","doi-asserted-by":"crossref","unstructured":"Guang HM, Du GH (2006). Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats. Eur J Pharmacol, 542: 77-83.","DOI":"10.1016\/j.ejphar.2006.04.054"},{"key":"key-10.14336\/AD.2025.0010-26","doi-asserted-by":"crossref","unstructured":"He XL, Wang YH, Gao M, Li XX, Zhang TT, Du GH (2009). Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage. Brain Res, 1249: 212-221.","DOI":"10.1016\/j.brainres.2008.10.005"},{"key":"key-10.14336\/AD.2025.0010-27","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, et al. (2021). NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway. J Neuroinflammation, 18: 207.","DOI":"10.1186\/s12974-021-02250-8"},{"key":"key-10.14336\/AD.2025.0010-28","doi-asserted-by":"crossref","unstructured":"Dong XX, Wang Y, Qin ZH (2009). Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta pharmacologica Sinica, 30: 379-387.","DOI":"10.1038\/aps.2009.24"},{"key":"key-10.14336\/AD.2025.0010-29","doi-asserted-by":"crossref","unstructured":"Rungta RL, Choi HB, Tyson JR, Malik A, Dissing-Olesen L, et al. (2015). The cellular mechanisms of neuronal swelling underlying cytotoxic edema. Cell, 161: 610-621.","DOI":"10.1016\/j.cell.2015.03.029"},{"key":"key-10.14336\/AD.2025.0010-30","doi-asserted-by":"crossref","unstructured":"Verma M, Lizama BN, Chu CT (2022). Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener, 11: 3.","DOI":"10.1186\/s40035-021-00278-7"},{"key":"key-10.14336\/AD.2025.0010-31","doi-asserted-by":"crossref","unstructured":"Olloquequi J, Cornejo-C\u00f3rdova E, Verdaguer E, Soriano FX, Binvignat O, Auladell C, Camins A (2018). Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications. J Psychopharmacol, 32: 265-275.","DOI":"10.1177\/0269881118754680"},{"key":"key-10.14336\/AD.2025.0010-32","doi-asserted-by":"crossref","unstructured":"Wang J, Zhang HY, Tang XC (2009). Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta Pharmacol Sin, 30: 879-888.","DOI":"10.1038\/aps.2009.82"},{"key":"key-10.14336\/AD.2025.0010-33","unstructured":"Tanovi\u0107 A, Alfaro V (2006). Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia. Rev Neurol, 42: 607-616."},{"key":"key-10.14336\/AD.2025.0010-34","doi-asserted-by":"crossref","unstructured":"Gavirolva SI, Kolykhalov IV, Mikhaylova NM, Ponomareva EV, Fedorova YB, et al. (2024). Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 124: 69-77.","DOI":"10.17116\/jnevro202412402169"},{"key":"key-10.14336\/AD.2025.0010-35","doi-asserted-by":"crossref","unstructured":"Zhang X, Shi X, Wang J, Xu Z, He J (2021). Enriched environment remedies cognitive dysfunctions and synaptic plasticity through NMDAR-Ca2+-Activin A circuit in chronic cerebral hypoperfusion rats. Aging, 13: 20748-20761.","DOI":"10.18632\/aging.203462"},{"key":"key-10.14336\/AD.2025.0010-36","doi-asserted-by":"crossref","unstructured":"Luca M, Luca A, Calandra C (2015). The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia. Oxid Med Cell Longev, 2015, 504678.","DOI":"10.1155\/2015\/504678"},{"key":"key-10.14336\/AD.2025.0010-37","doi-asserted-by":"crossref","unstructured":"Di Meo S, Reed TT, Venditti P, Victor VM (2016). Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev, 2016: 1245049.","DOI":"10.1155\/2016\/1245049"},{"key":"key-10.14336\/AD.2025.0010-38","doi-asserted-by":"crossref","unstructured":"Salim S (2017). Oxidative Stress and the Central Nervous System. J Pharmacol Exp Ther, 360: 201-205.","DOI":"10.1124\/jpet.116.237503"},{"key":"key-10.14336\/AD.2025.0010-39","doi-asserted-by":"crossref","unstructured":"Cobley JN, Fiorello ML, Bailey DM (2018). 13 reasons why the brain is susceptible to oxidative stress. Redox Biol, 15: 490-503.","DOI":"10.1016\/j.redox.2018.01.008"},{"key":"key-10.14336\/AD.2025.0010-40","doi-asserted-by":"crossref","unstructured":"Jelinek M, Jurajda M, Duris K (2021). Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke. Antioxidants (Basel), 10: 1886.","DOI":"10.3390\/antiox10121886"},{"key":"key-10.14336\/AD.2025.0010-41","doi-asserted-by":"crossref","unstructured":"Wu L, Xiong X, Wu X, Ye Y, Jian Z, Zhi Z, Gu L (2020). Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury. Front Mol Neurosci, 13: 28.","DOI":"10.3389\/fnmol.2020.00028"},{"key":"key-10.14336\/AD.2025.0010-42","doi-asserted-by":"crossref","unstructured":"Liu H, Zhang J (2012). Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress. Int J Neurosci, 122: 494-499.","DOI":"10.3109\/00207454.2012.686543"},{"key":"key-10.14336\/AD.2025.0010-43","doi-asserted-by":"crossref","unstructured":"Carvalho C, Moreira PI (2018). Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events. Front Physiol, 9: 806.","DOI":"10.3389\/fphys.2018.00806"},{"key":"key-10.14336\/AD.2025.0010-44","doi-asserted-by":"crossref","unstructured":"Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, et al. (2014). The global burden of ischemic stroke. Global Heart, 9: 107-112.","DOI":"10.1016\/j.gheart.2014.01.001"},{"key":"key-10.14336\/AD.2025.0010-45","doi-asserted-by":"crossref","unstructured":"Saxena AK, Abdul-Majeed SS, Gurtu S, Mohamed WM (2015). Investigation of redox status in chronic cerebral hypoperfusion-induced neurodegeneration in rats. Appl Transl Genom, 5: 30-32.","DOI":"10.1016\/j.atg.2015.05.004"},{"key":"key-10.14336\/AD.2025.0010-46","doi-asserted-by":"crossref","unstructured":"Liu L, Zhang P, Li Y, Yu G (2012). Curcumin protects brain from oxidative stress through inducing expression of UCP2 in chronic cerebral hypoperfusion aging-rats. Mol Neurodegener, 7: S10.","DOI":"10.1186\/1750-1326-7-S1-S10"},{"key":"key-10.14336\/AD.2025.0010-47","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhang JJ, Xiong L, Zhang L, Sun D, Liu H (2010). Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J Nutr Biochem, 21: 741-748.","DOI":"10.1016\/j.jnutbio.2009.05.002"},{"key":"key-10.14336\/AD.2025.0010-48","doi-asserted-by":"crossref","unstructured":"Nedeljkovic ZS, Gokce N, Loscalzo J (2003). Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J, 79: 195-200.","DOI":"10.1136\/pmj.79.930.195"},{"key":"key-10.14336\/AD.2025.0010-49","doi-asserted-by":"crossref","unstructured":"Xiang C, Wang Y, Zhang H, Han F (2017). The role of endoplasmic reticulum stress in neurodegenerative disease. Apoptosis, 22: 1-26.","DOI":"10.1007\/s10495-016-1296-4"},{"key":"key-10.14336\/AD.2025.0010-50","doi-asserted-by":"crossref","unstructured":"Hetz C, Saxena S (2017). ER stress and the unfolded protein response in neurodegeneration. Nature reviews. Neurology, 13: 477-491.","DOI":"10.1038\/nrneurol.2017.99"},{"key":"key-10.14336\/AD.2025.0010-51","doi-asserted-by":"crossref","unstructured":"Wu CX, Liu R, Gao M, Zhao G, Wu S, Wu CF, Du GH (2013). Pinocembrin protects brain against ischemia\/reperfusion injury by attenuating endoplasmic reticulum stress induced apoptosis. Neurosci Lett, 546: 57-62.","DOI":"10.1016\/j.neulet.2013.04.060"},{"key":"key-10.14336\/AD.2025.0010-52","doi-asserted-by":"crossref","unstructured":"Niu XL, Jiang X, Xu GD, Zheng GM, Tang ZP, et al. (2019). DL\u20103\u2010 n \u2010butylphthalide alleviates vascular cognitive impairment by regulating endoplasmic reticulum stress and the Shh\/Ptch1 signaling\u2010pathway in rats. J Cell Physiol, 234: 12604-12614.","DOI":"10.1002\/jcp.27332"},{"key":"key-10.14336\/AD.2025.0010-53","doi-asserted-by":"crossref","unstructured":"Tanaka KI, Kawahara M (2017). Copper Enhances Zinc-Induced Neurotoxicity and the Endoplasmic Reticulum Stress Response in a Neuronal Model of Vascular Dementia. Front Neurosci, 11: 58.","DOI":"10.3389\/fnins.2017.00058"},{"key":"key-10.14336\/AD.2025.0010-54","doi-asserted-by":"crossref","unstructured":"Kawahara M, Sadakane Y, Koyama H, Konoha K, Ohkawara S (2013). D-histidine and L-histidine attenuate zinc-induced neuronal death in GT1-7 cells. Metallomics, 5: 453-460.","DOI":"10.1039\/c3mt20264j"},{"key":"key-10.14336\/AD.2025.0010-55","doi-asserted-by":"crossref","unstructured":"DiSabato DJ, Quan N, Godbout JP (2016). Neuroinflammation: the devil is in the details. J Neurochem, 139: 136-153.","DOI":"10.1111\/jnc.13607"},{"key":"key-10.14336\/AD.2025.0010-56","doi-asserted-by":"crossref","unstructured":"Amor S, Puentes F, Baker D, van der Valk P (2010). Inflammation in neurodegenerative diseases. Immunology, 129: 154-169.","DOI":"10.1111\/j.1365-2567.2009.03225.x"},{"key":"key-10.14336\/AD.2025.0010-57","doi-asserted-by":"crossref","unstructured":"Du SQ, Wang XR, Xiao LY, Tu JF, Zhu W, He T, Liu CZ (2017). Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?. Mol Neurobiol, 54: 3670-3682.","DOI":"10.1007\/s12035-016-9915-1"},{"key":"key-10.14336\/AD.2025.0010-58","doi-asserted-by":"crossref","unstructured":"Matsuyama H, Shindo A, Shimada T, Yata K, Wakita H, Takahashi R, Tomimoto H (2020). Chronic cerebral hypoperfusion activates AIM2 and NLRP3 inflammasome. Brain Res, 1736: 146779.","DOI":"10.1016\/j.brainres.2020.146779"},{"key":"key-10.14336\/AD.2025.0010-59","doi-asserted-by":"crossref","unstructured":"Poh L, Fann DY, Wong P, Lim HM, Foo SL, Kang SW, Rajeev V, Selvaraji S, Iyer VR, et al. (2021). AIM2 inflammasome mediates hallmark neuropathological alterations and cognitive impairment in a mouse model of vascular dementia. Mol Psychiatry, 26: 4544-4560.","DOI":"10.1038\/s41380-020-00971-5"},{"key":"key-10.14336\/AD.2025.0010-60","doi-asserted-by":"crossref","unstructured":"Miyanohara J, Kakae M, Nagayasu K, Nakagawa T, Mori Y, Arai K, Shirakawa H, Kaneko S. (2018). TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion. J Neurosci, 38: 3520-3533.","DOI":"10.1523\/JNEUROSCI.2451-17.2018"},{"key":"key-10.14336\/AD.2025.0010-61","doi-asserted-by":"crossref","unstructured":"Chen WW, Zhang X, Huang WJ (2016). Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep, 13: 3391-3396.","DOI":"10.3892\/mmr.2016.4948"},{"key":"key-10.14336\/AD.2025.0010-62","doi-asserted-by":"crossref","unstructured":"Kuang H, Zhou ZF, Zhu YG, Wan ZK, Yang MW, Hong FF, Yang SL (2021). Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective. Aging Dis, 12: 308-326.","DOI":"10.14336\/AD.2020.0427"},{"key":"key-10.14336\/AD.2025.0010-63","doi-asserted-by":"crossref","unstructured":"Quintana D, Ren X, Hu H, Corbin D, Engler-Chiurazzi E, Alvi M, Simpkins J (2021). IL-1\u03b2 Antibody Protects Brain from Neuropathology of Hypoperfusion. Cells, 10: 855.","DOI":"10.3390\/cells10040855"},{"key":"key-10.14336\/AD.2025.0010-64","doi-asserted-by":"crossref","unstructured":"Wang QG, Xue X, Yang Y, Gong PY, Jiang T, Zhang YD (2018). Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion. J Renin Angiotensin Aldosterone Syst, 19: 1470320318799587.","DOI":"10.1177\/1470320318799587"},{"key":"key-10.14336\/AD.2025.0010-65","doi-asserted-by":"crossref","unstructured":"Maloney B, Lahiri DK (2016). Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol, 15: 760-774.","DOI":"10.1016\/S1474-4422(16)00065-X"},{"key":"key-10.14336\/AD.2025.0010-66","doi-asserted-by":"crossref","unstructured":"Weinhold B (2006). Epigenetics: the science of change. Environ Health Perspect, 114: A160-7.","DOI":"10.1289\/ehp.114-a160"},{"key":"key-10.14336\/AD.2025.0010-67","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang YZ, Jiang J, Duan CG (2020). The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation. Front Genet, 11: 998.","DOI":"10.3389\/fgene.2020.00998"},{"key":"key-10.14336\/AD.2025.0010-68","doi-asserted-by":"crossref","unstructured":"Liu B, Yip R, Zhou Z (2012). Chromatin remodeling, DNA damage repair and aging. Curr Genomics, 13: 533-547.","DOI":"10.2174\/138920212803251373"},{"key":"key-10.14336\/AD.2025.0010-69","doi-asserted-by":"crossref","unstructured":"Hu Z, Chen K, Li W, Tyler JK (2014). A matter of access. Nucleosome disassembly from gene promoters is the central goal of transcriptional activators. Transcription, 5:e29355.","DOI":"10.4161\/trns.29355"},{"key":"key-10.14336\/AD.2025.0010-70","doi-asserted-by":"crossref","unstructured":"Moore LD, Le T, Fan G (2013). DNA methylation and its basic function. Neuropsychopharmacology, 38: 23-38.","DOI":"10.1038\/npp.2012.112"},{"key":"key-10.14336\/AD.2025.0010-71","doi-asserted-by":"crossref","unstructured":"Kim S, Kaang BK (2017). Epigenetic regulation and chromatin remodeling in learning and memory. Exp Mol Med, 49: e281.","DOI":"10.1038\/emm.2016.140"},{"key":"key-10.14336\/AD.2025.0010-72","doi-asserted-by":"crossref","unstructured":"Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD (2009). Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PloS one, 4: e6617.","DOI":"10.1371\/journal.pone.0006617"},{"key":"key-10.14336\/AD.2025.0010-73","doi-asserted-by":"crossref","unstructured":"Smith RG, Pishva E, Shireby G, Smith AR, Roubroeks JAY, Hannon E, Wheildon G, et al. (2021). A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex. Nat Commun, 12: 3517.","DOI":"10.1038\/s41467-021-23243-4"},{"key":"key-10.14336\/AD.2025.0010-74","doi-asserted-by":"crossref","unstructured":"Xu H, Li S, Liu YS (2021). Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases. Front Cell Dev Biol, 9: 699374.","DOI":"10.3389\/fcell.2021.699374"},{"key":"key-10.14336\/AD.2025.0010-75","doi-asserted-by":"crossref","unstructured":"Veerappan CS, Sleiman S, Coppola G (2013). Epigenetics of Alzheimer's disease and frontotemporal dementia. Neurotherapeutics, 10: 709-721.","DOI":"10.1007\/s13311-013-0219-0"},{"key":"key-10.14336\/AD.2025.0010-76","doi-asserted-by":"crossref","unstructured":"Fenoglio C, Scarpini E, Serpente M, Galimberti D (2018). Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia. J Alzheimers Dis, 62: 913-932.","DOI":"10.3233\/JAD-170702"},{"key":"key-10.14336\/AD.2025.0010-77","doi-asserted-by":"crossref","unstructured":"Selvaraji S, Efthymios M, Foo RSY, Fann DY, Lai MKP, Chen CLH, Lim KL, Arumugam TV (2022). Time-Restricted Feeding Modulates the DNA Methylation Landscape, Attenuates Hallmark Neuropathology and Cognitive Impairment in a Mouse Model of Vascular Dementia. Theranostics, 12: 3007-3023.","DOI":"10.7150\/thno.71815"},{"key":"key-10.14336\/AD.2025.0010-78","doi-asserted-by":"crossref","unstructured":"Park JM, Kim YJ, Song MK, Lee JM, Kim YJ (2018). Genome wide DNA methylation profiling in a rat model with vascular dementia. Mol Med Rep, 18: 123-130.","DOI":"10.3892\/mmr.2018.8990"},{"key":"key-10.14336\/AD.2025.0010-79","doi-asserted-by":"crossref","unstructured":"Jin B, Robertson KD (2013). DNA methyltransferases (DNMTs), DNA damage repair, and cancer. Adv Exp Med Biol, 754: 3-29.","DOI":"10.1007\/978-1-4419-9967-2_1"},{"key":"key-10.14336\/AD.2025.0010-80","doi-asserted-by":"crossref","unstructured":"Jeltsch A, Ehrenhofer-Murray A, Jurkowski TP, Lyko F, Reuter G, Ankri S, Nellen W, Schaefer M, Helm M (2017). Mechanism and biological role of Dnmt2 in Nucleic Acid Methylation. RNA Biol, 14: 1108-1123.","DOI":"10.1080\/15476286.2016.1191737"},{"key":"key-10.14336\/AD.2025.0010-81","doi-asserted-by":"crossref","unstructured":"Jin B, Li Y, Robertson KD (2011). DNA methylation: superior or subordinate in the epigenetic hierarchy?. Genes Cancer, 2: 607-617.","DOI":"10.1177\/1947601910393957"},{"key":"key-10.14336\/AD.2025.0010-82","doi-asserted-by":"crossref","unstructured":"Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, Zhang K, Ming GL, Gao Y, Song H (2011). Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci, 14: 1345-1351.","DOI":"10.1038\/nn.2900"},{"key":"key-10.14336\/AD.2025.0010-83","doi-asserted-by":"crossref","unstructured":"Rasmussen KD, Helin K (2016). Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev, 30: 733-750.","DOI":"10.1101\/gad.276568.115"},{"key":"key-10.14336\/AD.2025.0010-84","doi-asserted-by":"crossref","unstructured":"Wu SC, Zhang Y (2010). Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol, 11: 607-620.","DOI":"10.1038\/nrm2950"},{"key":"key-10.14336\/AD.2025.0010-85","doi-asserted-by":"crossref","unstructured":"Weber AR, Krawczyk C, Robertson AB, Ku\u015bnierczyk A, V\u00e5gb\u00f8 CB, Schuermann D, Klungland A, Sch\u00e4r P (2016). Biochemical reconstitution of TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated mechanism. Nat Commun, 7: 10806.","DOI":"10.1038\/ncomms10806"},{"key":"key-10.14336\/AD.2025.0010-86","doi-asserted-by":"crossref","unstructured":"Wu X, Zhang Y (2017). TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet, 18: 517-534.","DOI":"10.1038\/nrg.2017.33"},{"key":"key-10.14336\/AD.2025.0010-87","doi-asserted-by":"crossref","unstructured":"Bednarska-Makaruk M, Graban A, Sobczy\u0144ska-Malefora A, Harrington DJ, et al. (2016). Homocysteine metabolism and the associations of global DNA methylation with selected gene polymorphisms and nutritional factors in patients with dementia. Exp Gerontol, 81: 83-91.","DOI":"10.1016\/j.exger.2016.05.002"},{"key":"key-10.14336\/AD.2025.0010-88","doi-asserted-by":"crossref","unstructured":"Smith AR, Smith RG, Burrage J, Troakes C, Al-Sarraj S, Kalaria RN, Sloan C, Robinson AC, Mill J, Lunnon K (2019). A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases. Neurobiol Aging, 74: 70-76.","DOI":"10.1016\/j.neurobiolaging.2018.09.024"},{"key":"key-10.14336\/AD.2025.0010-89","doi-asserted-by":"crossref","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, Troakes C, et al. (2014). Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci, 17: 1164-1170.","DOI":"10.1038\/nn.3782"},{"key":"key-10.14336\/AD.2025.0010-90","doi-asserted-by":"crossref","unstructured":"Wu X, Sun J, Li L (2013). Chronic cerebrovascular hypoperfusion affects global DNA methylation and histone acetylation in rat brain. Neurosci Bull, 29: 685-692.","DOI":"10.1007\/s12264-013-1345-8"},{"key":"key-10.14336\/AD.2025.0010-91","doi-asserted-by":"crossref","unstructured":"Wu X, Sun J, Zhang X, Li X, Liu Z, Yang Q, Li L (2014). Epigenetic signature of chronic cerebral hypoperfusion and beneficial effects of S-adenosylmethionine in rats. Mol Neurobiol, 50: 839-851.","DOI":"10.1007\/s12035-014-8698-5"},{"key":"key-10.14336\/AD.2025.0010-92","doi-asserted-by":"crossref","unstructured":"Kooistra SM, Helin K (2012). Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol, 13: 297-311.","DOI":"10.1038\/nrm3327"},{"key":"key-10.14336\/AD.2025.0010-93","doi-asserted-by":"crossref","unstructured":"Molina-Serrano D, Kyriakou D, Kirmizis A (2019). Histone Modifications as an Intersection Between Diet and Longevity. Front Genet, 10: 192.","DOI":"10.3389\/fgene.2019.00192"},{"key":"key-10.14336\/AD.2025.0010-94","doi-asserted-by":"crossref","unstructured":"Karli\u0107 R, Chung HR, Lasserre J, Vlahovicek K, Vingron M (2010). Histone modification levels are predictive for gene expression. Proc Natl Acad Sci U S A, 107: 2926-2931.","DOI":"10.1073\/pnas.0909344107"},{"key":"key-10.14336\/AD.2025.0010-95","doi-asserted-by":"crossref","unstructured":"B\u00e1rtov\u00e1 E, Krejc\u00ed J, Harnicarov\u00e1 A, Galiov\u00e1 G, Kozubek S (2008). Histone modifications and nuclear architecture: a review. J Histochem Cytochem, 56: 711-721.","DOI":"10.1369\/jhc.2008.951251"},{"key":"key-10.14336\/AD.2025.0010-96","doi-asserted-by":"crossref","unstructured":"Verdone L, Caserta M, Di Mauro E (2005). Role of histone acetylation in the control of gene expression. Biochem Cell Biol, 83: 344-353.","DOI":"10.1139\/o05-041"},{"key":"key-10.14336\/AD.2025.0010-97","doi-asserted-by":"crossref","unstructured":"Greer EL, Shi Y (2012). Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet, 13: 343-357.","DOI":"10.1038\/nrg3173"},{"key":"key-10.14336\/AD.2025.0010-98","doi-asserted-by":"crossref","unstructured":"Rossetto D, Avvakumov N, C\u00f4t\u00e9 J (2012). Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics, 7: 1098-1108.","DOI":"10.4161\/epi.21975"},{"key":"key-10.14336\/AD.2025.0010-99","doi-asserted-by":"crossref","unstructured":"Banerjee T, Chakravarti D (2011). A peek into the complex realm of histone phosphorylation. Mol Cell Biol, 31: 4858-4873.","DOI":"10.1128\/MCB.05631-11"},{"key":"key-10.14336\/AD.2025.0010-100","doi-asserted-by":"crossref","unstructured":"Zhang Y (2003). Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev, 17: 2733-2740.","DOI":"10.1101\/gad.1156403"},{"key":"key-10.14336\/AD.2025.0010-101","doi-asserted-by":"crossref","unstructured":"Bannister AJ, Kouzarides T (2011). Regulation of chromatin by histone modifications. Cell Res, 21: 381-395.","DOI":"10.1038\/cr.2011.22"},{"key":"key-10.14336\/AD.2025.0010-102","doi-asserted-by":"crossref","unstructured":"Wojcik F, Dann GP, Beh LY, Debelouchina GT, Hofmann R, Muir TW (2018). Functional crosstalk between histone H2B ubiquitylation and H2A modifications and variants. Nat Commun, 9: 1394.","DOI":"10.1038\/s41467-018-03895-5"},{"key":"key-10.14336\/AD.2025.0010-103","doi-asserted-by":"crossref","unstructured":"Cao J, Yan Q (2012). Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol, 2: 26.","DOI":"10.3389\/fonc.2012.00026"},{"key":"key-10.14336\/AD.2025.0010-104","doi-asserted-by":"crossref","unstructured":"Wang J, Qiu Z, Wu Y (2018). Ubiquitin Regulation: The Histone Modifying Enzyme's Story. Cells, 7: 118.","DOI":"10.3390\/cells7090118"},{"key":"key-10.14336\/AD.2025.0010-105","doi-asserted-by":"crossref","unstructured":"Cobos SN, Bennett SA, Torrente MP (2019). The impact of histone post-translational modifications in neurodegenerative diseases. Biochim Biophys Acta Mol Basis Dis, 1865: 1982-1991.","DOI":"10.1016\/j.bbadis.2018.10.019"},{"key":"key-10.14336\/AD.2025.0010-106","doi-asserted-by":"crossref","unstructured":"Markus HS, M\u00e4kel\u00e4 KM, Bevan S, Raitoharju E, Oksala N, Bis JC, O'Donnell C, Hainsworth A, Lehtim\u00e4ki T (2013). Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke, 44: 1220-1225.","DOI":"10.1161\/STROKEAHA.111.000217"},{"key":"key-10.14336\/AD.2025.0010-107","doi-asserted-by":"crossref","unstructured":"Azghandi S, Prell C, van der Laan SW, Schneider M, Malik R, Berer K, Gerdes N, Pasterkamp G, Weber C, Haffner C, Dichgans M (2015). Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1. Stroke, 46: 197-202.","DOI":"10.1161\/STROKEAHA.114.007213"},{"key":"key-10.14336\/AD.2025.0010-108","doi-asserted-by":"crossref","unstructured":"Yang Q, Wu X, Sun J, Cui J, Li L (2014). Epigenetic features induced by ischemia-hypoxia in cultured rat astrocytes. Mol Neurobiol, 53: 436-445.","DOI":"10.1007\/s12035-014-9027-8"},{"key":"key-10.14336\/AD.2025.0010-109","doi-asserted-by":"crossref","unstructured":"Mecocci P, Ekman R, Parnetti L, Senin U (1993). Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. Biol Psychiatry, 34: 380-385.","DOI":"10.1016\/0006-3223(93)90182-D"},{"key":"key-10.14336\/AD.2025.0010-110","doi-asserted-by":"crossref","unstructured":"Liu H, Zhang JJ, Li X, Yang Y, Xie XF, Hu K (2015). Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion. Pharmacol Biochem Behav, 135: 53-59.","DOI":"10.1016\/j.pbb.2015.05.012"},{"key":"key-10.14336\/AD.2025.0010-111","doi-asserted-by":"crossref","unstructured":"Sharma B, Singh N (2011). Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology (Berl), 215: 677-687.","DOI":"10.1007\/s00213-011-2164-0"},{"key":"key-10.14336\/AD.2025.0010-112","doi-asserted-by":"crossref","unstructured":"Sharma B, Sharma PM (2013). Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors. Toxicol Appl Pharmacol, 273: 180-188.","DOI":"10.1016\/j.taap.2013.07.017"},{"key":"key-10.14336\/AD.2025.0010-113","doi-asserted-by":"crossref","unstructured":"Kaur N, Fang YC, Lee HY, Singh A, Nepali K, Lin MH, Yeh TK, Lai MJ, Chan L, Tu YK, Banerjee S, Hu CJ, Liou JP (2020). Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment. Eur J Med Chem, 187: 111915.","DOI":"10.1016\/j.ejmech.2019.111915"},{"key":"key-10.14336\/AD.2025.0010-114","doi-asserted-by":"crossref","unstructured":"Fang YC, Chan L, Liou JP, Tu YK, Lai MJ, et al. (2020). HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression. J Cell Mol Med, 24: 6966-6977.","DOI":"10.1111\/jcmm.15358"},{"key":"key-10.14336\/AD.2025.0010-115","doi-asserted-by":"crossref","unstructured":"Fang YC, Hsieh JY, Vidyanti AN, Yang CH, et al. (2021). HDACi protects against vascular cognitive impairment from CCH injury via induction of BDNF-related AMPA receptor activation. J Cell Mol Med, 25: 7418-7425.","DOI":"10.1111\/jcmm.16770"},{"key":"key-10.14336\/AD.2025.0010-116","doi-asserted-by":"crossref","unstructured":"Wan Q, Ma X, Zhang ZJ, Sun T, Xia F, Zhao G, Wu YM (2017). Ginsenoside Reduces Cognitive Impairment During Chronic Cerebral Hypoperfusion Through Brain-Derived Neurotrophic Factor Regulated by Epigenetic Modulation. Mol Neurobiol, 54: 2889-2900.","DOI":"10.1007\/s12035-016-9868-4"},{"key":"key-10.14336\/AD.2025.0010-117","doi-asserted-by":"crossref","unstructured":"Jian WX, Zhang Z, Zhan JH, Chu SF, Peng Y, Zhao M, Wang Q, Chen NH (2020). Donepezil attenuates vascular dementia in rats through increasing BDNF induced by reducing HDAC6 nuclear translocation. Acta Pharmacol Sin, 41: 588-598.","DOI":"10.1038\/s41401-019-0334-5"},{"key":"key-10.14336\/AD.2025.0010-118","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhang J, Xiong L, Deng M, Wang J, Xin J, Liu H (2015). Cognitive Improvement Induced by Environment Enrichment in Chronic Cerebral Hypoperfusion Rats: a Result of Upregulated Endogenous Neuroprotection?. J Mol Neurosci, 56: 278-289.","DOI":"10.1007\/s12031-015-0529-2"},{"key":"key-10.14336\/AD.2025.0010-119","doi-asserted-by":"crossref","unstructured":"Eddy SR (2001). Non-coding RNA genes and the modern RNA world. Nat Rev Genet, 2: 919-929.","DOI":"10.1038\/35103511"},{"key":"key-10.14336\/AD.2025.0010-120","doi-asserted-by":"crossref","unstructured":"Watson CN, Belli A, Di Pietro V (2019). Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease. Front Genet, 10: 364.","DOI":"10.3389\/fgene.2019.00364"},{"key":"key-10.14336\/AD.2025.0010-121","doi-asserted-by":"crossref","unstructured":"Santosh B, Varshney A, Yadava PK (2015). Non-coding RNAs: biological functions and applications. Cell Biochem Funct, 33: 14-22.","DOI":"10.1002\/cbf.3079"},{"key":"key-10.14336\/AD.2025.0010-122","doi-asserted-by":"crossref","unstructured":"Mattick JS, Makunin IV (2006). Non-coding RNA. Hum Mol Genet, 15: R17-R29.","DOI":"10.1093\/hmg\/ddl046"},{"key":"key-10.14336\/AD.2025.0010-123","doi-asserted-by":"crossref","unstructured":"Moazed D (2009). Small RNAs in transcriptional gene silencing and genome defence. Nature, 457: 413-420.","DOI":"10.1038\/nature07756"},{"key":"key-10.14336\/AD.2025.0010-124","doi-asserted-by":"crossref","unstructured":"Wang DQ, Fu P, Yao C, Zhu LS, Hou TY, Chen JG, et al. (2018). Long Non-coding RNAs, Novel Culprits, or Bodyguards in Neurodegenerative Diseases. Mol Ther Nucleic Acids, 10: 269-276.","DOI":"10.1016\/j.omtn.2017.12.011"},{"key":"key-10.14336\/AD.2025.0010-125","doi-asserted-by":"crossref","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M (2021). Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol, 22: 96-118.","DOI":"10.1038\/s41580-020-00315-9"},{"key":"key-10.14336\/AD.2025.0010-126","doi-asserted-by":"crossref","unstructured":"Ayers D, Scerri C (2018). Non-coding RNA influences in dementia. Noncoding RNA Res, 3: 188-194.","DOI":"10.1016\/j.ncrna.2018.09.002"},{"key":"key-10.14336\/AD.2025.0010-127","doi-asserted-by":"crossref","unstructured":"Zhang X, Huang X, Fang C, Li Q, Cui J, Sun J, Li L (2017). miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion. Mol Neurobiol, 54: 2498-2506.","DOI":"10.1007\/s12035-016-9845-y"},{"key":"key-10.14336\/AD.2025.0010-128","doi-asserted-by":"crossref","unstructured":"Zhang S, Yan ML, Yang L, An XB, Zhao HM, Xia SN, Jin Z, Huang SY, Qu Y, Ai J (2020). MicroRNA-153 impairs hippocampal synaptic vesicle trafficking via downregulation of synapsin I in rats following chronic cerebral hypoperfusion. Exp Neurol, 332: 113389.","DOI":"10.1016\/j.expneurol.2020.113389"},{"key":"key-10.14336\/AD.2025.0010-129","doi-asserted-by":"crossref","unstructured":"Yu P, Venkat P, Chopp M, Zacharek A, Shen Y, Ning R, Liang L, Li W, Zhang L, Landschoot-Ward J, Jiang R, Chen J (2019). Role of microRNA-126 in vascular cognitive impairment in mice. J Cereb Blood Flow Metab, 39: 2497-2511.","DOI":"10.1177\/0271678X18800593"},{"key":"key-10.14336\/AD.2025.0010-130","doi-asserted-by":"crossref","unstructured":"Xie H, Zhao Y, Zhou Y, Liu L, Liu Y, Wang D, Zhang S, Yang M (2017). MiR-9 Regulates the Expression of BACE1 in Dementia Induced by Chronic Brain Hypoperfusion in Rats. Cell Physiol Biochem, 42: 1213-1226.","DOI":"10.1159\/000478919"},{"key":"key-10.14336\/AD.2025.0010-131","doi-asserted-by":"crossref","unstructured":"Ai J, Sun LH, Che H, Zhang R, Zhang TZ, Wu WC, Su XL, Chen X, Yang G, Li K, Wang N, Ban T, Bao YN, Guo F, Niu HF, Zhu YL, Zhu XY, Zhao SG, Yang BF (2013). MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J Neurosci, 33: 3989-4001.","DOI":"10.1523\/JNEUROSCI.1997-12.2013"},{"key":"key-10.14336\/AD.2025.0010-132","doi-asserted-by":"crossref","unstructured":"Sun LH, Yan ML, Hu XL, Peng LW, Che H, et al. (2015). MicroRNA-9 induces defective trafficking of Nav1.1 and Nav1.2 by targeting Nav\u03b22 protein coding region in rat with chronic brain hypoperfusion. Mol Neurodegener, 10: 36.","DOI":"10.1186\/s13024-015-0032-9"},{"key":"key-10.14336\/AD.2025.0010-133","doi-asserted-by":"crossref","unstructured":"Liu CD, Wang Q, Zong DK, Pei SC, Yan Y, et al. (2016). Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion. Neurobiol Aging, 45: 76-87.","DOI":"10.1016\/j.neurobiolaging.2016.05.010"},{"key":"key-10.14336\/AD.2025.0010-134","doi-asserted-by":"crossref","unstructured":"Mao M, Xu Y, Zhang XY, Yang L, An XB, et al. (2020). MicroRNA-195 prevents hippocampal microglial\/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1\/CX3CR1 signaling. J Neuroinflammation, 17: 244.","DOI":"10.1186\/s12974-020-01919-w"},{"key":"key-10.14336\/AD.2025.0010-135","doi-asserted-by":"crossref","unstructured":"Chen X, Jiang XM, Zhao LJ, Sun LL, Yan ML, Tian Y, Zhang S, Duan MJ, Zhao HM, Li WR, Hao YY, Wang LB, Xiong QJ, Ai J (2017). MicroRNA-195 prevents dendritic degeneration and neuron death in rats following chronic brain hypoperfusion. Cell Death Dis, 8: e2850.","DOI":"10.1038\/cddis.2017.243"},{"key":"key-10.14336\/AD.2025.0010-136","doi-asserted-by":"crossref","unstructured":"Tan Z, Chen Y,Xie W, Liu X, Zhu Y, Zhu Y (2018). Nimodipine attenuates tau phosphorylation at Ser396 via miR-132\/GSK-3\u03b2 pathway in chronic cerebral hypoperfusion rats. Eur J Pharmacol, 819: 1-8.","DOI":"10.1016\/j.ejphar.2017.10.027"},{"key":"key-10.14336\/AD.2025.0010-137","doi-asserted-by":"crossref","unstructured":"Wang L, Yang JW, Lin LT, Huang J, Wang XR, Su XT, Cao Y, Fisher M, Liu CZ (2020). Acupuncture Attenuates Inflammation in Microglia of Vascular Dementia Rats by Inhibiting miR-93-Mediated TLR4\/MyD88\/NF-\u03baB Signaling Pathway. Oxid Med Cell Longev, 2020: 8253904.","DOI":"10.1155\/2020\/8253904"},{"key":"key-10.14336\/AD.2025.0010-138","doi-asserted-by":"crossref","unstructured":"Niu Y, Wan C, Zhang J, Zhang S, Zhao Z, Zhu L, Wang X, Ren X, Wang J, Lei P (2021). Aerobic exercise improves VCI through circRIMS2\/miR-186\/BDNF-mediated neuronal apoptosis. Mol Med, 27: 4.","DOI":"10.1186\/s10020-020-00258-z"},{"key":"key-10.14336\/AD.2025.0010-139","doi-asserted-by":"crossref","unstructured":"Shi H, Sun F, Yang T, Peng M, Wang M, Zhang Y, Wang Y, Dong C, Yan Z, Si G, Wang W, Li Y (2021). Construction of a ceRNA immunoregulatory network related to the development of vascular dementia through a weighted gene coexpression network analysis. Ann Transl Med, 9: 858.","DOI":"10.21037\/atm-21-1717"},{"key":"key-10.14336\/AD.2025.0010-140","doi-asserted-by":"crossref","unstructured":"Cummings J, Schwartz GG, Nicholls SJ, Khan A, Halliday C, Toth PP, et al. (2021). Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial. J Alzheimers Dis, 83: 1703-1715.","DOI":"10.3233\/JAD-210570"},{"key":"key-10.14336\/AD.2025.0010-141","doi-asserted-by":"crossref","unstructured":"An Y, Feng L, Zhang X, Wang Y, Wang Y, Tao L, Qin Z, Xiao R (2019). Dietary intakes and biomarker patterns of folate, vitamin B6, and vitamin B12 can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1. Clin Epigenetics, 11: 139.","DOI":"10.1186\/s13148-019-0741-y"},{"key":"key-10.14336\/AD.2025.0010-142","doi-asserted-by":"crossref","unstructured":"Xie M, Jiang Q, Xie Y (2015). Comparison between decitabine and azacitidine for the treatment of myelodysplastic syndrome: a meta-analysis with 1,392 participants. Clin Lymphoma Myeloma Leuk, 15: 22-8.","DOI":"10.1016\/j.clml.2014.04.010"},{"key":"key-10.14336\/AD.2025.0010-143","doi-asserted-by":"crossref","unstructured":"West AC, Johnstone RW (2014). New and emerging HDAC inhibitors for cancer treatment. J Clin Invest,124: 30-39.","DOI":"10.1172\/JCI69738"},{"key":"key-10.14336\/AD.2025.0010-144","doi-asserted-by":"crossref","unstructured":"Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, Xu Y (2017). HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease. Aging Cell, 16:1073-1082.","DOI":"10.1111\/acel.12642"},{"key":"key-10.14336\/AD.2025.0010-145","doi-asserted-by":"crossref","unstructured":"Belmonte KCD, Holmgren EB, Wills TA, Gidday JM (2022). Epigenetic conditioning induces intergenerational resilience to dementia in a mouse model of vascular cognitive impairment. Alzheimers Dement, 18:1711-1720.","DOI":"10.1002\/alz.12616"},{"key":"key-10.14336\/AD.2025.0010-146","doi-asserted-by":"crossref","unstructured":"Surguchov A, Bernal L, Surguchev AA (2021). Phytochemicals as Regulators of Genes Involved in Synucleinopathies. Biomolecules, 11: 624.","DOI":"10.3390\/biom11050624"},{"key":"key-10.14336\/AD.2025.0010-147","doi-asserted-by":"crossref","unstructured":"Hassan FU, Rehman MS, Khan MS, Ali MA, Javed A, Nawaz A, Yang C (2019). Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. Front Genet, 10: 514.","DOI":"10.3389\/fgene.2019.00514"},{"key":"key-10.14336\/AD.2025.0010-148","doi-asserted-by":"crossref","unstructured":"Chen J, Ying Y, Zhu H, Zhu T, Qu C, Jiang J, Fang B (2019). Curcumin-induced promoter hypermethylation of the mammalian target of rapamycin gene in multiple myeloma cells. Oncol Lett, 17: 1108-1114.","DOI":"10.3892\/ol.2018.9662"},{"key":"key-10.14336\/AD.2025.0010-149","doi-asserted-by":"crossref","unstructured":"Kalani A, Kamat PK, Kalani K, Tyagi N (2015). Epigenetic impact of curcumin on stroke prevention. Metab Brain Dis, 30: 427-435.","DOI":"10.1007\/s11011-014-9537-0"},{"key":"key-10.14336\/AD.2025.0010-150","doi-asserted-by":"crossref","unstructured":"Farhan M, Ullah MF, Faisal M, Farooqi AA, Sabitaliyevich UY, Biersack B, Ahmad A (2019). Differential Methylation and Acetylation as the Epigenetic Basis of Resveratrol's Anticancer Activity. Medicines (Basel), 6: 24.","DOI":"10.3390\/medicines6010024"},{"key":"key-10.14336\/AD.2025.0010-151","doi-asserted-by":"crossref","unstructured":"Fernandes GFS, Silva GDB, Pavan AR, Chiba DE, Chin CM, Dos Santos JL (2017). Epigenetic Regulatory Mechanisms Induced by Resveratrol. Nutrients, 9: 1201.","DOI":"10.3390\/nu9111201"},{"key":"key-10.14336\/AD.2025.0010-152","doi-asserted-by":"crossref","unstructured":"Libro R, Giacoppo S, Soundara Rajan T, Bramanti P, Mazzon E (2016). Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview. Molecules, 21: 518.","DOI":"10.3390\/molecules21040518"},{"key":"key-10.14336\/AD.2025.0010-153","doi-asserted-by":"crossref","unstructured":"Barr\u00f3n-Cabrera E, Ramos-Lopez O, Gonz\u00e1lez-Becerra K, Riezu-Boj JI, Milagro FI, Mart\u00ednez-L\u00f3pez E, Mart\u00ednez JA (2019). Epigenetic Modifications as Outcomes of Exercise Interventions Related to Specific Metabolic Alterations: A Systematic Review. Lifestyle Genom, 12: 25-44.","DOI":"10.1159\/000503289"},{"key":"key-10.14336\/AD.2025.0010-154","doi-asserted-by":"crossref","unstructured":"Axsom JE, Libonati JR (2019). Impact of parental exercise on epigenetic modifications inherited by offspring: A systematic review. Physiol Rep, 7: e14287.","DOI":"10.14814\/phy2.14287"},{"key":"key-10.14336\/AD.2025.0010-155","doi-asserted-by":"crossref","unstructured":"Zeng Z, Deng YH, Shuai T, Zhuang H, Wang Y, Song GM (2016). Effect of physical activity training on dementia patients: a systematic review with a meta-analysis. Chinese Nursing Research, 3: 168-175.","DOI":"10.1016\/j.cnre.2016.11.006"},{"key":"key-10.14336\/AD.2025.0010-156","doi-asserted-by":"crossref","unstructured":"Lee JM, Park JM, Song MK, Oh YJ, Kim CJ, Kim YJ (2017). The ameliorative effects of exercise on cognitive impairment and white matter injury from blood-brain barrier disruption induced by chronic cerebral hypoperfusion in adolescent rats. Neurosci Lett, 638: 83-89.","DOI":"10.1016\/j.neulet.2016.12.018"},{"key":"key-10.14336\/AD.2025.0010-157","doi-asserted-by":"crossref","unstructured":"Liu-Ambrose T, Best JR, Davis JC, Eng JJ, Lee PE, et al. (2016). Aerobic exercise and vascular cognitive impairment: A randomized controlled trial. Neurology, 87: 2082-2090.","DOI":"10.1212\/WNL.0000000000003332"},{"key":"key-10.14336\/AD.2025.0010-158","doi-asserted-by":"crossref","unstructured":"McGee SL, Hargreaves M (2019). Epigenetics and Exercise. Trends Endocrinol Metab, 30: 636-645.","DOI":"10.1016\/j.tem.2019.06.002"},{"key":"key-10.14336\/AD.2025.0010-159","doi-asserted-by":"crossref","unstructured":"Sellami M, Bragazzi N, Prince MS, Denham J, Elrayess M (2021). Regular, Intense Exercise Training as a Healthy Aging Lifestyle Strategy: Preventing DNA Damage, Telomere Shortening and Adverse DNA Methylation Changes Over a Lifetime. Front Genet, 12: 652497.","DOI":"10.3389\/fgene.2021.652497"},{"key":"key-10.14336\/AD.2025.0010-160","doi-asserted-by":"crossref","unstructured":"Seaborne RA, Sharples AP (2020). The Interplay Between Exercise Metabolism, Epigenetics, and Skeletal Muscle Remodeling. Exerc Sport Sci Rev, 48: 188-200.","DOI":"10.1249\/JES.0000000000000227"},{"key":"key-10.14336\/AD.2025.0010-161","doi-asserted-by":"crossref","unstructured":"Grazioli E, Dimauro I, Mercatelli N, Wang G, Pitsiladis Y, Di Luigi L, Caporossi D (2017). Physical activity in the prevention of human diseases: role of epigenetic modifications. BMC Genomics, 18: 802.","DOI":"10.1186\/s12864-017-4193-5"},{"key":"key-10.14336\/AD.2025.0010-162","unstructured":"Yong-Quan Ng G, Yang-Wei Fann D, Jo DG, Sobey CG, Arumugam TV (2019). Dietary Restriction and Epigenetics: Part I. Cond Med, 2: 284-299."},{"key":"key-10.14336\/AD.2025.0010-163","doi-asserted-by":"crossref","unstructured":"Green CL, Lamming DW, Fontana L (2022). Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol, 23: 56-73.","DOI":"10.1038\/s41580-021-00411-4"},{"key":"key-10.14336\/AD.2025.0010-164","doi-asserted-by":"crossref","unstructured":"Gensous N, Franceschi C, Santoro A, Milazzo M, Garagnani P, Bacalini MG (2019). The Impact of Caloric Restriction on the Epigenetic Signatures of Aging. Int J Mol Sci, 20: 2022.","DOI":"10.3390\/ijms20082022"},{"key":"key-10.14336\/AD.2025.0010-165","doi-asserted-by":"crossref","unstructured":"Mattson MP, Longo VD, Harvie M (2017). Impact of intermittent fasting on health and disease processes. Ageing Res Rev, 39: 46-58.","DOI":"10.1016\/j.arr.2016.10.005"},{"key":"key-10.14336\/AD.2025.0010-166","doi-asserted-by":"crossref","unstructured":"Klempel MC, Kroeger CM, Bhutani S, Trepanowski JF, Varady KA (2012). Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J, 11: 98.","DOI":"10.1186\/1475-2891-11-98"},{"key":"key-10.14336\/AD.2025.0010-167","doi-asserted-by":"crossref","unstructured":"Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA, Mattson MP (2003). Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci U S A, 100: 6216-6220.","DOI":"10.1073\/pnas.1035720100"},{"key":"key-10.14336\/AD.2025.0010-168","doi-asserted-by":"crossref","unstructured":"Pak HH, Haws SA, Green CL, Koller M, Lavarias MT, Richardson NE, Yang SE, Dumas SN, Sonsalla M, Bray L, Johnson M, Barnes S, Darley-Usmar V, Zhang J, Yen CE, Denu JM, Lamming DW (2021). Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice. Nat Metab, 3: 1327-1341.","DOI":"10.1038\/s42255-021-00466-9"},{"key":"key-10.14336\/AD.2025.0010-169","doi-asserted-by":"crossref","unstructured":"Mandal S, Simmons N, Awan S, Chamari K, Ahmed I (2022). Intermittent fasting: eating by the clock for health and exercise performance. BMJ Open Sport Exerc Med, 8: e001206.","DOI":"10.1136\/bmjsem-2021-001206"},{"key":"key-10.14336\/AD.2025.0010-170","doi-asserted-by":"crossref","unstructured":"Asif S, Morrow NM, Mulvihill EE, Kim KH (2020). Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases. Front Genet, 11, 590369.","DOI":"10.3389\/fgene.2020.590369"},{"key":"key-10.14336\/AD.2025.0010-171","doi-asserted-by":"crossref","unstructured":"Hjort L, J\u00f8rgensen SW, Gillberg L, Hall E, Br\u00f8ns C, Frystyk J, Vaag AA, Ling C (2017). 36 h fasting of young men influences adipose tissue DNA methylation of LEP and ADIPOQ in a birth weight-dependent manner. Clin Epigenetics, 9: 40.","DOI":"10.1186\/s13148-017-0340-8"},{"key":"key-10.14336\/AD.2025.0010-172","doi-asserted-by":"crossref","unstructured":"Yin W, Liang Y, Sun L, Yin Y, Zhang W (2021). Maternal intermittent fasting before mating alters hepatic DNA methylation in offspring. Epigenomics, 13: 341-356.","DOI":"10.2217\/epi-2020-0403"},{"key":"key-10.14336\/AD.2025.0010-173","doi-asserted-by":"crossref","unstructured":"Yoon G, Song J (2019). Intermittent Fasting: a Promising Approach for Preventing Vascular Dementia. J Lipid Atheroscler, 8: 1-7.","DOI":"10.12997\/jla.2019.8.1.1"},{"key":"key-10.14336\/AD.2025.0010-174","doi-asserted-by":"crossref","unstructured":"Rajeev V, Tabassum NI, Fann DY, Chen CP, Lai MKP, Arumugam TV (2024). Intermittent Metabolic Switching and Vascular Cognitive Impairment. J Obes Metab Syndr, 33: 92-107.","DOI":"10.7570\/jomes24010"},{"key":"key-10.14336\/AD.2025.0010-175","doi-asserted-by":"crossref","unstructured":"Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Jo DG, Drummond GR, Sobey CG, Lai MKP, Chen CL, Arumugam TV (2022). Intermittent Fasting Attenuates Hallmark Vascular and Neuronal Pathologies in a Mouse Model of Vascular Cognitive Impairment. Int J Biol Sci, 18: 6052-6067.","DOI":"10.7150\/ijbs.75188"},{"key":"key-10.14336\/AD.2025.0010-176","doi-asserted-by":"crossref","unstructured":"Yao ZH, Wang J, Shen BZ, Li YT, Yao XL, Zhang SF, Zhang Y, Hu JC, Xie YC (2020). Identification of a hippocampal lncRNA-regulating network in cognitive dysfunction caused by chronic cerebral hypoperfusion. Aging (Albany NY), 11;12(19):19520-19538.","DOI":"10.18632\/aging.103901"},{"key":"key-10.14336\/AD.2025.0010-177","doi-asserted-by":"crossref","unstructured":"Fang C, Li Q, Min G, Liu M, Cui J, Sun J, Li L (2017). MicroRNA-181c Ameliorates Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. Mol Neurobiol, 54(10):8370-8385.","DOI":"10.1007\/s12035-016-0268-6"},{"key":"key-10.14336\/AD.2025.0010-178","doi-asserted-by":"crossref","unstructured":"Hu XL, Wang XX, Zhu YM, Xuan LN, Peng LW, Liu YQ, Yang H, Yang C, Jiao L, Hang PZ, Sun LH (2019). MicroRNA-132 regulates total protein of Nav1.1 and Nav1.2 in the hippocampus and cortex of rat with chronic cerebral hypoperfusion. Behav Brain Res, 2;366:118-125.","DOI":"10.1016\/j.bbr.2019.03.026"},{"key":"key-10.14336\/AD.2025.0010-179","doi-asserted-by":"crossref","unstructured":"Yao ZH, Yao XL, Zhang Y, Zhang SF, Hu J (2017). miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion. Curr Neurovasc Res, 14(4):385-396.","DOI":"10.2174\/1567202614666171101115308"},{"key":"key-10.14336\/AD.2025.0010-180","doi-asserted-by":"crossref","unstructured":"Liu P, Liu P, Wang Z, Fang S, Liu Y, Wang J, Liu W, Wang N, Chen L, Wang J, Zhang H, Wang L (2018). Inhibition of MicroRNA-96 Ameliorates Cognitive Impairment and Inactivation Autophagy Following Chronic Cerebral Hypoperfusion in the Rat. Cell Physiol Biochem, 49(1):78-86.","DOI":"10.1159\/000492844"},{"key":"key-10.14336\/AD.2025.0010-181","doi-asserted-by":"crossref","unstructured":"Toyama K, Spin JM, Deng AC, Huang TT, Wei K, Wagenh\u00e4user MU, et al. (2018). MicroRNA-Mediated Therapy Modulating Blood-Brain Barrier Disruption Improves Vascular Cognitive Impairment. Arterioscler Thromb Vasc Biol, 38(6):1392-1406.","DOI":"10.1161\/ATVBAHA.118.310822"},{"key":"key-10.14336\/AD.2025.0010-182","doi-asserted-by":"crossref","unstructured":"Li Q, Cui J, Fang C, Zhang X, Li L (2016). S-adenosylmethionine Administration Attenuates Low Brain-Derived Neurotrophic Factor Expression Induced by Chronic Cerebrovascular Hypoperfusion or Beta Amyloid Treatment. Neurosci Bull, 32(2):153-61.","DOI":"10.1007\/s12264-016-0023-z"},{"key":"key-10.14336\/AD.2025.0010-183","doi-asserted-by":"crossref","unstructured":"Yan ML, Zhang S, Zhao HM, Xia SN, Jin Z, Xu Y, Yang L, Qu Y, et al. (2020). MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion. Cell Commun Signal, 6;18(1):57.","DOI":"10.1186\/s12964-020-00551-8"},{"key":"key-10.14336\/AD.2025.0010-184","doi-asserted-by":"crossref","unstructured":"Che H, Yan Y, Kang XH, Guo F, Yan ML, Liu HL, Hou X, et al. (2017). MicroRNA-27a Promotes Inefficient Lysosomal Clearance in the Hippocampi of Rats Following Chronic Brain Hypoperfusion. Mol Neurobiol, 54(4):2595-2610.","DOI":"10.1007\/s12035-016-9856-8"},{"key":"key-10.14336\/AD.2025.0010-185","doi-asserted-by":"crossref","unstructured":"Sun LH, Ban T, Liu CD, Chen QX, Wang X, Yan ML, Hu XL, et al. (2015). Activation of Cdk5\/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation. J Neurochem, 134(6):1139-51.","DOI":"10.1111\/jnc.13212"},{"key":"key-10.14336\/AD.2025.0010-186","doi-asserted-by":"crossref","unstructured":"Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, et al. (2019). Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data. Commun Biol, 25;2:77.","DOI":"10.1038\/s42003-019-0324-7"},{"key":"key-10.14336\/AD.2025.0010-187","doi-asserted-by":"crossref","unstructured":"Liao LX, Zhao MB, Dong X, Jiang Y, Zeng KW, Tu PF (2016). TDB protects vascular endothelial cells against oxygen-glucose deprivation\/reperfusion-induced injury by targeting miR-34a to increase Bcl-2 expression. Sci Rep, 6:37959.","DOI":"10.1038\/srep37959"},{"key":"key-10.14336\/AD.2025.0010-188","doi-asserted-by":"crossref","unstructured":"Liu X, Zhang R, Wu Z, Si W, Ren Z, Zhang S, Zhou J, Chen D (2019). miR\u2011134\u20115p\/Foxp2\/Syn1 is involved in cognitive impairment in an early vascular dementia rat model. Int J Mol Med, 44(5):1729-1740.","DOI":"10.3892\/ijmm.2019.4331"},{"key":"key-10.14336\/AD.2025.0010-189","doi-asserted-by":"crossref","unstructured":"Huang K, Yang C, Zheng J, Liu X, Liu J, Che D, Xue Y, An P, Wang D, Ruan X, Yu B (2021). Effect of circular RNA, mmu_circ_0000296, on neuronal apoptosis in chronic cerebral ischaemia via the miR-194-5p\/Runx3\/Sirt1 axis. Cell Death Disco, 7(1):124.","DOI":"10.1038\/s41420-021-00507-y"},{"key":"key-10.14336\/AD.2025.0010-190","doi-asserted-by":"crossref","unstructured":"Wei C, Xu X, Zhu H, Zhang X, Gao Z (2021). Promotive role of microRNA\u2011150 in hippocampal neurons apoptosis in vascular dementia model rats. Mol Med Rep, 23(4):257.","DOI":"10.3892\/mmr.2021.11896"},{"key":"key-10.14336\/AD.2025.0010-191","doi-asserted-by":"crossref","unstructured":"Prabhakar P, Chandra SR, Christopher R (2017). Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease. Age Ageing, 46(5):861-864.","DOI":"10.1093\/ageing\/afx090"},{"key":"key-10.14336\/AD.2025.0010-192","unstructured":"Deng Y, Chen ZJ, Qi HX, Sun XP, Li D (2024). Correlations of Expression Levels of microRNA-206 and microRNA-186 in the Serum With Disease Severity and Prognosis of Elderly Patients With Vascular Dementia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 46(6):883-889."},{"key":"key-10.14336\/AD.2025.0010-193","doi-asserted-by":"crossref","unstructured":"Deng Y, Duan R, Hong Y, Peng Q, Li ZY, Chen XL, Zhang YD (2024). Trimethylamine N-Oxide Aggravates Neuro-Inflammation via lncRNA Fendrr\/miR-145-5p\/PXN Axis in Vascular Dementia Rats. J Inflamm Res, 17:7441-7461.","DOI":"10.2147\/JIR.S479154"},{"key":"key-10.14336\/AD.2025.0010-194","doi-asserted-by":"crossref","unstructured":"Liu X, Yao L, Ye X, Qin Y, Chen S, Jiang Q, Liu M, Chen X, et al. (2024). Danggui-Shaoyao-San (DSS) ameliorating cognitive impairment in ischemia-reperfusion vascular dementia mice through miR-124 regulating PI3K\/Akt signaling pathway. Brain Res, 1845:149135.","DOI":"10.1016\/j.brainres.2024.149135"},{"key":"key-10.14336\/AD.2025.0010-195","doi-asserted-by":"crossref","unstructured":"Zhang B, Deng L, Liu X, Hu Y, Wang W, Li M, et al. (2024). Transcranial direct current stimulation combined with swimming exercise improves the learning and memory abilities of vascular dementia rats by regulating microglia through miR-223-3p\/PRMT8. Neurol Res, 46(6):525-537.","DOI":"10.1080\/01616412.2024.2337517"},{"key":"key-10.14336\/AD.2025.0010-196","doi-asserted-by":"crossref","unstructured":"Song YT, Li SS, Chao CY, Shuang-Guo, Chen GZ, Wang SX, et al. (2024). Floralozone regulates MiR-7a-5p expression through AMPK\u03b12 activation to improve cognitive dysfunction in vascular dementia. Exp Neuro, 376:114748.","DOI":"10.1016\/j.expneurol.2024.114748"},{"key":"key-10.14336\/AD.2025.0010-197","doi-asserted-by":"crossref","unstructured":"Li N, Ren C, Li S, Yu W, Jin K, Ji X (2023). Remote ischemic conditioning alleviates chronic cerebral hypoperfusion-induced cognitive decline and synaptic dysfunction via the miR-218a-5p\/SHANK2 pathway. Prog Neurobiol, 230:102514.","DOI":"10.1016\/j.pneurobio.2023.102514"},{"key":"key-10.14336\/AD.2025.0010-198","doi-asserted-by":"crossref","unstructured":"Toyama K, Spin JM, Tsao PS, Maruyama K, Osawa H, Mogi M, Takata Y (2023). Serum microRNA-501-3p is a potential diagnostic tool for detecting mild cognitive impairment: Ehime genome study. J Neurochem, 166(6):960-971.","DOI":"10.1111\/jnc.15911"},{"key":"key-10.14336\/AD.2025.0010-199","doi-asserted-by":"crossref","unstructured":"Sun T, Tan L, Liu M, Zeng L, Zhao K, Cai Z, Sun S, Li Z, Liu R (2023). Tilianin improves cognition in a vascular dementia rodent model by targeting miR-193b-3p\/CaM- and miR-152-3p\/CaMKII\u03b1-mediated inflammatory and apoptotic pathways. Front Immunol, 19;14:1118808.","DOI":"10.3389\/fimmu.2023.1118808"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T01:10:15Z","timestamp":1738890615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2025.0010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":199,"URL":"https:\/\/doi.org\/10.14336\/ad.2025.0010","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}